All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| Sibiricoside B | CHEBI_81169 | |
| Eleganin | CHEBI_4770 | |
| Elemicin | CHEBI_4771 | |
| CHEBI_4772 | CHEBI_4772 | |
| Elephantopin | CHEBI_4773 | |
| (-)-Pinoresinol glucoside | CHEBI_81162 | |
| plantagoside | CHEBI_81163 | [A flavanone glycoside that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7, 4' and 5' and a beta-D-glucopyranosyloxy group at position 3' respectively.] |
| Metoxadiazone | CHEBI_81164 | |
| Gambirtannine | CHEBI_81165 | |
| Rengyol | CHEBI_81160 | |
| beta-Hydroxyacteoside | CHEBI_81161 | |
| Encecalin | CHEBI_4789 | |
| enalapril maleate | CHEBI_4785 | [The maleic acid salt of enalapril. It contains one molecule of maleic acid for each molecule of enalapril. Following oral administration, the ethyl ester group of enalapril is hydrolysed to afford the corresponding carboxylic acid, enalaprilat, an angiotensin-converting enzyme (ACE) inhibitor. Enalapril is thus a prodrug for enalaprilat (which, unlike enalapril, is not absorbed by mouth), and its maleate is used in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients.] |
| enalapril | CHEBI_4784 | [A dicarboxylic acid monoester that is ethyl 4-phenylbutanoate in which a hydrogen alpha to the carboxy group is substituted by the amino group of L-alanyl-L-proline (S-configuration).] |
| Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-(L-alanyl)-D-alanyl-D-alanine | CHEBI_81177 | |
| enalaprilat (anhydrous) | CHEBI_4786 | [Enalapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid. Enalaprilat is an angiotensin-converting enzyme (ACE) inhibitor and is used (often in the form of its prodrug, enalapril) in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. Unlike enalapril, enalaprilat is not absorbed by mouth but is given by intravenous injection, usually as the dihydrate.] |
| 2-Polyprenyl-6-hydroxyphenol | CHEBI_81178 | |
| Enalkiren | CHEBI_4787 | |
| 2-Polyprenyl-6-methoxyphenol | CHEBI_81179 | |
| encainide | CHEBI_4788 | [4-Methoxy-N-phenylbenzamide in which the hydrogen at the 2 position of the phenyl group is substituted by a 2-(1-methylpiperidin-2-yl)ethyl group. A class Ic antiarrhythmic, the hydrochloride was used for the treatment of severe or life-threatening ventricular arrhythmias, but it was associated with increased death rates in patients who had asymptomatic heart rhythm abnormalities after a recent heart attack and was withdrawn from the market.] |